MBRX Moleculin Biotech Inc
Company Analysis
Latest News
🔴 Moleculin Biotech is trading 15.6% down today as it extends a multi-day slide amid cash runway and clinical trial concerns
Moleculin Biotech is trading 15.6% down today at $0.86 as the stock extends a sharp multi-day slide amid investor focus on its cash runway and clinical trial...
🟢 Moleculin Biotech is trading 17.6% up today as it rebounds from a sharp multi-day selloff
Moleculin Biotech is trading 17.6% up at $1.20 in pre-market action, rebounding after two sessions of steep losses that drove shares from $2.19 down to...
🟢 Moleculin Biotech is trading 6.5% up today as it stabilizes after a heavy selloff
Moleculin Biotech is trading 6.5% up at $1.09 in pre-market action, showing signs of stabilization following two days of heavy losses. • The stock recently...
🔴 Moleculin Biotech is trading 10.3% down today on follow-through pressure after yesterday's sharp drop
Moleculin Biotech is trading at $1.24 (10.3% down) as the stock continues to face selling pressure following a significant decline in the previous session. •...
🔴 Moleculin Biotech is trading 14.8% down today on heavy early-session weakness with no fresh news
Moleculin Biotech is trading 14.8% down at $1.86 on heavy early-session weakness, despite no fresh company-specific news being identified so far. • The...
🟢 Moleculin Biotech is trading 6.6% up today amid a broader biotech sector rally
Moleculin Biotech is trading at $2.26 (+6.60%) following a strong intraday rebound, despite a lack of company-specific news, earnings, or FDA catalysts. The...
🔴 Moleculin Biotech is trading 5.5% down today amid broader biotech weakness and 52-week lows
Moleculin Biotech is trading 5.5% down at $2.18 today, extending recent weakness as the stock hits a new 52-week low amid broader market risk-off sentiment. •...
🔴 Moleculin Biotech is trading 5.7% down today amid profit-taking after recent gains
Moleculin Biotech is trading 5.7% down at $2.30, giving back a portion of its recent gains following a strong upward move that began in late June. • The...
🔴 Moleculin Biotech Inc is trading 5.11% down in pre-market
MBRX is trading at $2.20, down 5.11% in pre-market.
🔴 MBRX is trading 5% down today after disappointing trial results and Q1 earnings miss
MBRX is trading 5% down at $2.28 as investors react to disappointing interim cancer trial results and a significant Q1 2026 earnings miss. • The stock has...
🔴 MBRX is trading 5% down today after disappointing trial data and earnings miss
MBRX is trading 5% down at $2.51 in pre-market, extending a multi-day slide following disappointing interim cancer trial data and a sizable Q1 2026 earnings...
🔴 MBRX is trading 6.7% down today following disappointing interim clinical trial data
MBRX is trading 6.7% down at $2.51 today, as investor sentiment continues to be impacted by recent interim clinical trial data. • On June 30, 2026, Moleculin...
🔴 MBRX is trading 5% down today after interim cancer trial data falls short of statistical significance
• MBRX shares plunged after the company announced interim results from its Phase 2/3 MIRACLE trial for Annamycin in relapsed or refractory acute myeloid...
Moleculin Biotech raises approximately $2.7 million from recent warrant exercises
Moleculin Biotech, Inc. announced it received approximately $2.7 million in gross proceeds from the exercise of warrants subsequent to its last quarterly...
Moleculin Reports Positive Interim Phase 2/3 Data for Annamycin in AML Trial
Moleculin Biotech, Inc. (MBRX) announced positive preliminary efficacy results from its pivotal Phase 2/3 MIRACLE trial for Annamycin in treating relapsed or...
🔴 MBRX Plunges 17.5% Despite Positive MIRACLE Trial Data, as Dilution Concerns and Profit-Taking Weigh
MBRX is trading 17.5% down at $2.94 today. • This decline occurs despite Moleculin Biotech announcing positive preliminary unblinded efficacy results from its...
Moleculin's $8.3 Million Cash Grab Came With a Catch — Can a Micro-Cap Biotech Survive Doubling Its Share Count?
Shares of Moleculin Biotech (MBRX) plunged 19.4% to $2.88 as the lingering shadow of a February 2026 warrant deal continues to crush investor confidence. The...
🔴 MBRX is trading 19.4% down today after $2.7M warrant exercises
• Moleculin Biotech reported warrant exercises for 1,361,500 shares, generating approximately $2.7 million in gross proceeds, as of June 29, 2026. • The...
🔴 MBRX is trading 5.3% down today on profit-taking after a 20% weekly rally
MBRX is trading 5.3% down at $3.38 as investors lock in gains following a significant multi-day run-up. • Shares had climbed more than 20% over the past week...
🟢 MBRX makes sharp 10.4% jump
MBRX is trading at $3.61, up 10.4% versus the comparison close of $3.27 during regular trading. This is a price-movement alert; no separate company-specific...